Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 4. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease 5. Rapid correction of low vitamin D status in nursing home residents
Top Ten Searches
etanercept hypertension chf antiphospholipid fibrosis mrsa scid renal cell rickets counterpulsationYour Article Summary
See Latest ArticlesPrescribing statins to patients with nonalcoholic fatty liver disease: Real cardiovascular benefits outweigh theoretical hepatotoxic risk
Cardiovascular Drug Reviews, 06/26/09
Riley P et al. – A review summarizes the evidence for and against the prescription of statins to pts with nonalcoholic fatty liver disease, a group typically associated with high cardiovascular risk.
Methods- Review of evidence for/against statin use in nonalcoholic fatty liver disease
- Statins are widely prescribed, with a significant role in reducing cardiovascular risk
- Concern for hepatic safety profile may prevent use for pts with concurrent liver pathology
- Contrary to current opinion, considerable evidence for and little evidence against prescription of statins to this population
- Guidelines advising against statin use in this setting should be reviewed
Today in Atherosclerosis/Lipids...keeping you current
Receive free subspecialty "5-minute updates" via email
Non-soy legume consumption lowers cholesterol levels: A meta-analysis of randomized controlled trials
Nutrition, Metabolism & Cardiovascular Diseases, 12/07/09
Endothelial activation, inflammation and premature atherosclerosis in children with familial dyslipidemia
Atherosclerosis, 12/07/09
Altered composition of triglyceride-rich lipoproteins and coronary artery disease in a large case–control study
Atherosclerosis, 12/07/09
Sponsor
Article Search
Sponsor
Sponsor